Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

12-week Randomized Study to Compare the Effect of Vildagliptin vs. Glibenclamide Associated to Metformin in Endothelial Function in Patients With Type 2 Diabetes and Hypertension

NCT02145611 is registered in ClinicalTrials.gov with Dr. José Fernando Vilela-Martin MD PhD as lead sponsor.

NCT NCT02145611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02145611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
12-week Randomized Study to Compare the Effect of Vildagliptin vs. Glibenclamide Associated to Metformin in Endothelial Function in Patients With Type 2 Diabetes and Hypertension
Lead sponsor
Dr. José Fernando Vilela-Martin MD PhD
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
May 31, 2016
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, hypertension, type 2 diabetes mellitus